Xiao Han
- Biomedical Engineering top 0.5%
- Molecular Biology top 5%
- Immunology top 1%
- Oncology top 2%
- Biomaterials top 0.5%
- Co-authors
- Zhuang LiuJun XuZiliang DongLigeng XuChao WangQian ChenChao LiangYu Chao
- Topics
- Nanoplatforms for cancer theranostics (20 papers)Lung Cancer Treatments and Mutations (19 papers)Cancer Immunotherapy and Biomarkers (16 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiao Han
137 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Biomedical Engineering 3.8k
- Molecular Biology 2.0k
- Immunology 1.8k
- Oncology 1.3k
- Biomaterials 1.3k
Countries citing papers authored by Xiao Han
This map shows the geographic impact of Xiao Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Han more than expected).
Fields of papers citing papers by Xiao Han
This network shows the impact of papers produced by Xiao Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Han. The network helps show where Xiao Han may publish in the future.
Co-authorship network of co-authors of Xiao Han
This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Han. A scholar is included among the top collaborators of Xiao Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Han. Xiao Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 13 | |
| 4 | 1 | |
| 5 | Multifunctional TiO2/C nanosheets derived from 3D metal–organic frameworks for mild-temperature-photothermal-sonodynamic-chemodynamic therapy under photoacoustic image guidancebreakdown → | 196 |
| 6 | 32 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 14 | |
| 10 | 1 | |
| 11 | 150 | |
| 12 | 8 | |
| 13 | 104 | |
| 14 | 131 | |
| 15 | 9 | |
| 16 | 9 | |
| 17 | 40 | |
| 18 | 76 | |
| 19 | Determination of Trace Lead and Cadmium in Traditional Chinese Medicine by Flow Injection-on-Line Preconcentration-Inductively Coupled Plasma Optical Emission Spectrometry | 1 |
| 20 | 37 |
About Xiao Han
Xiao Han is a scholar working on Oncology, Immunology and Cancer Research, having authored 143 papers that have together received 6.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), Lung Cancer Treatments and Mutations (19 papers) and Cancer Immunotherapy and Biomarkers (16 papers). The work is most often cited by research in Biomaterials (1.3k citations), Biomedical Engineering (3.8k citations) and Immunology (1.8k citations). Xiao Han has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhuang Liu, Jun Xu, Ziliang Dong, Ligeng Xu, Chao Wang, Qian Chen, Chao Liang, Yu Chao, Jiawen Chen and Rui Peng. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.